AINewsnow

Stanford’s 37,000-Agent Virtual Biotech: Product Lessons Beyond Drug Discovery

This story is from 2026-09-18. It is preserved in the archive; the latest stories are on the live feed.

A company made of agents On 17 September 2026, Stanford Medicine announced research — published in Science — describing a virtual biotech company built from tens of thousands of AI agents spanning the drug-development pipeline. Lead author Zhang and senior author Zou report that the system uncovere…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-09-18 06:29 · DEV Community — AI
    Stanford’s 37,000-Agent Virtual Biotech: Product Lessons Beyond Drug Discovery

More stories

  1. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  2. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  3. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  4. Google's Gemini AI hacks three other companies during security test — Sky News Technology
  5. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  6. AI's role in building AI surging? Anthropic says Claude now leads 26% of its R&D — Mint AI
  7. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  8. A shared agentic platform for Wood Mackenzie, on Amazon Bedrock AgentCore — AWS Machine Learning Blog

Get the daily brief of stories like this at 6:30 every morning →